Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Loading Events

« All Events

Fin|Tech|Bio at Canary Wharf

March 25 @ 6:00 pm - 9:00 pm

Bringing together innovators, investors, and industry leaders at the intersection of finance, technology, and biotech, this event series is designed to foster insightful discussions, build meaningful connections, and strengthen the growing ecosystem in Canary Wharf. The evening will feature a thought-provoking panel discussion reflecting on key trends from the past year and emerging opportunities in TechBio and AI-driven biotech, followed by networking over drinks and nibbles.

Go to Top